We are live on ! Find out more
BHC

Bowen Hanes & Co Portfolio holdings

AUM $4.11B
1-Year Est. Return 41.61%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+41.61%
3 Year Est. Return
+119.85%
5 Year Est. Return
+166.26%
10 Year Est. Return
+656.19%
AUM
$1.86B
AUM Growth
-$24.2M
Cap. Flow
-$42.9M
Cap. Flow %
-2.3%
Top 10 Hldgs %
19.87%
Holding
144
New
13
Increased
28
Reduced
63
Closed
10

Top Sells

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$24M
2
MDT icon
Medtronic
MDT
+$20.3M
3
MET icon
MetLife
MET
+$18M
4
OMC icon
Omnicom Group
OMC
+$17.9M
5
BWA icon
BorgWarner
BWA
+$17.8M

Sector Composition

Rank Sector Weight
1 Industrials 26.12%
2 Technology 15.74%
3 Consumer Staples 11.75%
4 Financials 11.22%
5 Materials 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RY icon
101
Royal Bank of Canada
RY
$292B
$1.02M 0.06%
15,145
CAT icon
102
Caterpillar
CAT
$373B
$929K 0.05%
10,015
+125
+1% +$11.3K
RTX icon
103
RTX Corp
RTX
$289B
$871K 0.05%
12,633
FLR icon
104
Fluor
FLR
$6.99B
$866K 0.05%
16,495
+200
+1% +$10.4K
NEE icon
105
NextEra Energy
NEE
$183B
$776K 0.04%
25,980
-2,000
-7% -$59.8K
YDKN
106
DELISTED
Yadkin Financial Corporation
YDKN
$740K 0.04%
21,600
INGR icon
107
Ingredion
INGR
$6.33B
$712K 0.04%
5,695
-805
-12% -$102K
ROK icon
108
Rockwell Automation
ROK
$52.4B
$615K 0.03%
4,575
BMY icon
109
Bristol-Myers Squibb
BMY
$132B
$614K 0.03%
10,505
-6,950
-40% -$380K
GILD icon
110
Gilead Sciences
GILD
$163B
$606K 0.03%
8,461
-2,880
-25% -$214K
GSK icon
111
GSK
GSK
$104B
$583K 0.03%
12,110
+400
+3% +$19.8K
UL icon
112
Unilever
UL
$141B
$562K 0.03%
12,271
-280,640
-96% -$13.1M
CPB icon
113
Campbell Soup
CPB
$6.58B
$550K 0.03%
9,100
DISCK
114
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$482K 0.03%
18,000
NSC icon
115
Norfolk Southern
NSC
$75B
$477K 0.03%
4,415
-7,500
-63% -$758K
CVX icon
116
Chevron
CVX
$383B
$438K 0.02%
3,725
VZ icon
117
Verizon
VZ
$193B
$419K 0.02%
7,854
MTX icon
118
Minerals Technologies
MTX
$2.25B
$386K 0.02%
5,000
AXP icon
119
American Express
AXP
$228B
$363K 0.02%
4,900
BWA icon
120
BorgWarner
BWA
$13.2B
$342K 0.02%
9,855
-551,028
-98% -$17.8M
Y
121
DELISTED
Alleghany Corp
Y
$341K 0.02%
561
DNB
122
DELISTED
Dun & Bradstreet
DNB
$335K 0.02%
2,765
PNR icon
123
Pentair
PNR
$10.6B
$294K 0.02%
7,817
BG icon
124
Bunge Global
BG
$20.4B
$264K 0.01%
3,655
-1,300
-26% -$86.6K
MRK icon
125
Merck
MRK
$321B
$252K 0.01%
4,495
-262
-6% -$15.3K

Similar funds

Bowen Hanes & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Bowen Hanes & Co held 144 positions worth $1.86B, down 1.3% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Bowen Hanes & Co's Q4 2016 filing shows 13 new, 28 increased, 63 reduced and 10 closed positions. Its largest new stake was Trane Technologies: 274,670 shares worth $20.6M. The largest sale was Kimberly-Clark, an estimated $24M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.

  • Bowen Hanes & Co's largest Q4 2016 buy was Trane Technologies: 274,670 shares worth $20.6M.
  • Bowen Hanes & Co added most to Manulife Financial in Q4 2016, an estimated $24.3M increase.
  • Bowen Hanes & Co's biggest Q4 2016 reduction was Kimberly-Clark, cutting an estimated $24M.
  • Bowen Hanes & Co fully exited Omnicom Group in Q4 2016, selling an estimated $17.9M.
  • Bowen Hanes & Co's ten largest holdings make up 20% of its $1.86B portfolio in Q4 2016.
  • Bowen Hanes & Co opened 13 new positions and closed 10 in Q4 2016.
  • Bowen Hanes & Co's portfolio value fell 1.3% quarter-over-quarter to $1.86B.

Based on Bowen Hanes & Co's 13F filing for Q4 2016, filed 14 Feb 2017.